No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Bevacizumab
-
Capillary Permeability
-
Female
-
Fluorescein Angiography
-
Humans
-
Intravitreal Injections
-
Male
-
Middle Aged
-
Retina / pathology
-
Retinal Telangiectasis / drug therapy*
-
Retinal Telangiectasis / physiopathology
-
Retreatment
-
Retrospective Studies
-
Subretinal Fluid
-
Tomography, Optical Coherence
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Visual Acuity / physiology
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Bevacizumab